The Association Between Humeral Lengthening and Clinical Outcomes After Reverse Shoulder Arthroplasty: A Systematic Review and Meta-analysis.

Abstract

The purpose of this study was to evaluate the relationship between humeral lengthening and clinical outcomes after reverse shoulder arthroplasty (RSA) with stratification based on measurement method and implant design. This systematic review was performed using PRISMA-P guidelines. PubMed/Medline, Cochrane Trials, and Embase were queried for articles evaluating the relationship between humeral lengthening and clinical outcomes inclusive of range of motion (ROM), strength, outcome scores, and pertinent complications (acromial and scapular spine fractures, nerve injury) after RSA. The relationship between humeral lengthening and clinical outcomes was reported descriptively overall and stratified by measurement method and implant design (globally medialized versus lateralized). A positive association was defined as increased humeral lengthening being associated with greater ROM, outcome scores, or a greater incidence of complications, whereas a negative association denoted that increased humeral lengthening was associated with poorer ROM, outcome scores, or a lower incidence of complications. Meta-analysis was performed to compare humeral lengthening between patients with and without fractures of the acromion or scapular spine. Twenty-two studies were included. Humeral lengthening was assessed as the acromiohumeral distance (AHD), the distance from the acromion to the greater tuberosity (AGT), the acromion to the deltoid tuberosity (ADT), and the acromion to the distal humerus (ADH). Of 11 studies that assessed forward elevation, a positive association with humeral lengthening was found in six, a negative association was found in one, and four studies reported no association. Of studies assessing internal rotation (n=9), external rotation (n=7), and abduction (n=4), all either identified a positive or lack of association with humeral lengthening. Studies assessing outcome scores (n=11) found either a positive (n=5) or no (n=6) association with humeral lengthening. Of the studies that assessed fractures of the acromion and/or scapular spine (n=6), two identified a positive association with humeral lengthening, one identified a negative association, and three identified no association. The single study that assessed the incidence of nerve injury identified a positive association with humeral lengthening. Meta-analysis was possible for AGT (n=2) and AHD (n=2); greater humeral lengthening was found in patients with fractures for studies using the AGT (mean difference, 4.5 mm [95%CI, 0.7-8.3]), but not the AHD. Limited study inclusion and heterogeneity prohibited identification of trends based on method of measuring humeral lengthening and implant design. The relationship between humeral lengthening and clinical outcomes after RSA remains unclear and requires future investigation using a standardized assessment method.